Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SPERO THERAPEUTICS, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2018-07-12 to 2025-12-31
Current total value of award: $31034069
Description: THIS MOD IS TO REVISE SOW FOR CLIN 2 TO REFLECT THE NEW DEVELOPMENT PLAN FOR TEBIPENENEM HBR FOLLOWING FDA FEEDBACK AT THE TYPE A MEETING, AS WELL AS THE COMPLETE RESPONSE LETTER RECEIVED IN JUNE 2022.